These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1449 related items for PubMed ID: 28446190
21. Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses. Santano R, Rubio R, Grau-Pujol B, Escola V, Muchisse O, Cuamba I, Vidal M, Cisteró P, Ruiz-Olalla G, Aguilar R, Demontis M, Jamine JC, Cossa A, Sacoor C, Cano J, Izquierdo L, Chitnis CE, Coppel RL, Chauhan V, Cavanagh D, Dutta S, Angov E, Gaur D, van Lieshout L, Zhan B, Muñoz J, Moncunill G, Dobaño C. Microbiol Spectr; 2021 Dec 22; 9(3):e0110921. PubMed ID: 34878303 [Abstract] [Full Text] [Related]
22. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. Nielsen MA, Staalsoe T, Kurtzhals JA, Goka BQ, Dodoo D, Alifrangis M, Theander TG, Akanmori BD, Hviid L. J Immunol; 2002 Apr 01; 168(7):3444-50. PubMed ID: 11907103 [Abstract] [Full Text] [Related]
23. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Duarte J, Deshpande P, Guiyedi V, Mécheri S, Fesel C, Cazenave PA, Mishra GC, Kombila M, Pied S. Malar J; 2007 Jan 04; 6():1. PubMed ID: 17204149 [Abstract] [Full Text] [Related]
24. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study. Dobaño C, Ubillos I, Jairoce C, Gyan B, Vidal M, Jiménez A, Santano R, Dosoo D, Nhabomba AJ, Ayestaran A, Aguilar R, Williams NA, Díez-Padrisa N, Lanar D, Chauhan V, Chitnis C, Dutta S, Gaur D, Angov E, Asante KP, Owusu-Agyei S, Valim C, Gamain B, Coppel RL, Cavanagh D, Beeson JG, Campo JJ, Moncunill G. BMC Med; 2019 Aug 14; 17(1):157. PubMed ID: 31409398 [Abstract] [Full Text] [Related]
25. The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas. Jepsen MP, Jogdand PS, Singh SK, Esen M, Christiansen M, Issifou S, Hounkpatin AB, Ateba-Ngoa U, Kremsner PG, Dziegiel MH, Olesen-Larsen S, Jepsen S, Mordmüller B, Theisen M. J Infect Dis; 2013 Aug 01; 208(3):479-88. PubMed ID: 23624363 [Abstract] [Full Text] [Related]
26. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2. Dejon-Agobe JC, Ateba-Ngoa U, Lalremruata A, Homoet A, Engelhorn J, Nouatin OP, Edoa JR, Fernandes JF, Esen M, Mouwenda YD, Betouke Ongwe EM, Massinga-Loembe M, Hoffman SL, Sim BKL, Theisen M, Kremsner PG, Adegnika AA, Lell B, Mordmüller B. Clin Infect Dis; 2019 Sep 27; 69(8):1377-1384. PubMed ID: 30561539 [Abstract] [Full Text] [Related]
27. Influence of the sickle cell trait on Plasmodium falciparum infectivity from naturally infected gametocyte carriers. Ngou CM, Bayibéki AN, Abate L, Makinde OS, Feufack-Donfack LB, Sarah-Matio EM, Bouopda-Tuedom AG, Taconet P, Moiroux N, Awono-Ambéné PH, Talman A, Ayong LS, Berry A, Nsango SE, Morlais I. BMC Infect Dis; 2023 May 10; 23(1):317. PubMed ID: 37165325 [Abstract] [Full Text] [Related]
28. Antibodies to rifin: a component of naturally acquired responses to Plasmodium falciparum variant surface antigens on infected erythrocytes. Abdel-Latif MS, Cabrera G, Köhler C, Kremsner PG, Luty AJ, 1-95/C Study Team. Am J Trop Med Hyg; 2004 Aug 10; 71(2):179-86. PubMed ID: 15306707 [Abstract] [Full Text] [Related]
29. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. Bousema T, Roeffen W, Meijerink H, Mwerinde H, Mwakalinga S, van Gemert GJ, van de Vegte-Bolmer M, Mosha F, Targett G, Riley EM, Sauerwein R, Drakeley C. PLoS One; 2010 Nov 29; 5(11):e14114. PubMed ID: 21124765 [Abstract] [Full Text] [Related]
30. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A. Sharling L, Enevold A, Sowa KM, Staalsoe T, Arnot DE. Malar J; 2004 Sep 06; 3():31. PubMed ID: 15350207 [Abstract] [Full Text] [Related]
31. Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas. Baptista BO, de Souza ABL, Riccio EKP, Bianco-Junior C, Totino PRR, Martins da Silva JH, Theisen M, Singh SK, Amoah LE, Ribeiro-Alves M, Souza RM, Lima-Junior JC, Daniel-Ribeiro CT, Pratt-Riccio LR. Malar J; 2022 Jan 04; 21(1):6. PubMed ID: 34983540 [Abstract] [Full Text] [Related]
32. Insight into phagocytosis of mature sexual (gametocyte) stages of Plasmodium falciparum using a human monocyte cell line. Bansal GP, Weinstein CS, Kumar N. Acta Trop; 2016 May 04; 157():96-101. PubMed ID: 26851166 [Abstract] [Full Text] [Related]
33. Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children. Bull PC, Lowe BS, Kaleli N, Njuga F, Kortok M, Ross A, Ndungu F, Snow RW, Marsh K. J Infect Dis; 2002 Jun 01; 185(11):1688-91. PubMed ID: 12023781 [Abstract] [Full Text] [Related]
34. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? Sutherland CJ. Mol Biochem Parasitol; 2009 Aug 01; 166(2):93-8. PubMed ID: 19450726 [Abstract] [Full Text] [Related]
35. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M, GMZ2 Trial Study Group. Vaccine; 2016 Aug 31; 34(38):4536-4542. PubMed ID: 27477844 [Abstract] [Full Text] [Related]
36. High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi. Coalson JE, Walldorf JA, Cohee LM, Ismail MD, Mathanga D, Cordy RJ, Marti M, Taylor TE, Seydel KB, Laufer MK, Wilson ML. Malar J; 2016 Nov 04; 15(1):527. PubMed ID: 27809907 [Abstract] [Full Text] [Related]
37. Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes. Muthui MK, Takashima E, Omondi BR, Kinya C, Muasya WI, Nagaoka H, Mwai KW, Orindi B, Wambua J, Bousema T, Drakeley C, Blagborough AM, Marsh K, Bejon P, Kapulu MC. Front Cell Infect Microbiol; 2021 Nov 04; 11():774537. PubMed ID: 34869075 [Abstract] [Full Text] [Related]
38. Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in mice. Coelho CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, Alani NAH, Muratova O, McCormack A, Kelnhofer E, Urban JF, Narum DL, Anderson C, Langhorne J, Nutman TB, Duffy PE. Vaccine; 2019 Feb 14; 37(8):1038-1045. PubMed ID: 30685251 [Abstract] [Full Text] [Related]
39. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A. Malar J; 2007 Aug 08; 6():107. PubMed ID: 17686163 [Abstract] [Full Text] [Related]
40. Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria. Addai-Mensah O, Seidel M, Amidu N, Maskus DJ, Kapelski S, Breuer G, Franken C, Owusu-Dabo E, Frempong M, Rakotozandrindrainy R, Schinkel H, Reimann A, Klockenbring T, Barth S, Fischer R, Fendel R. Malar J; 2016 Feb 05; 15():65. PubMed ID: 26850066 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]